Search alternatives:
significantly better » significantly greater (Expand Search), significantly higher (Expand Search), significantly lower (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease reverse » decreased levels (Expand Search)
better decrease » greater decrease (Expand Search), teer decrease (Expand Search), between decreased (Expand Search)
Showing 1 - 20 results of 8,228 for search '(( significantly better decrease ) OR ( significant decrease reverse ))', query time: 0.45s Refine Results
  1. 1
    Significant decrease of the coiled-coil score in the double proline-substituted CAHS3 mutant.

    Significant decrease of the coiled-coil score in the double proline-substituted CAHS3 mutant. by Akihiro Tanaka (342394)

    Published 2022
    Save to List
    Saved in:
  2. 2
    Propofol anesthesia or with surgery decreased the expression of p-CREB and SAHA reversed the reduction.

    Propofol anesthesia or with surgery decreased the expression of p-CREB and SAHA reversed the reduction. by Yunlin Feng (3043659)

    Published 2024
    “…Surgery under propofol anesthesia decreased the expression more significantly. (*<i>p</i> < 0.05 vs. …”
    Save to List
    Saved in:
  3. 3
    Socio-demographic and medical characteristics of patients with liver cancer.

    Socio-demographic and medical characteristics of patients with liver cancer. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Data cleaning and preparation algorithm.

    Data cleaning and preparation algorithm. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023.

    Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023.

    Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific.

    Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023.

    Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023.

    Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023.

    Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023.

    Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023.

    Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Regional and temporal burden of liver cancer in Kazakhstan (2014–2023).

    Regional and temporal burden of liver cancer in Kazakhstan (2014–2023). by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Reverse MR analysis data.

    Reverse MR analysis data. by Ying Zhao (16546)

    Published 2025
    Save to List
    Saved in:
  15. 15
    List of 1483 genes that were significantly (<i>P</i> < 0.1) increased or decreased in any galactose-treated sample.

    List of 1483 genes that were significantly (<i>P</i> < 0.1) increased or decreased in any galactose-treated sample. by Masaya Nagaya (13851123)

    Published 2022
    Save to List
    Saved in:
  16. 16
    Duration of blood pressure decrease.

    Duration of blood pressure decrease. by Ai Wei (120010)

    Published 2023
    Save to List
    Saved in:
  17. 17
    Results of GO analysis showing significantly enriched biological process (BP), cellular component (CC) and molecular function (MF) in genes with significantly decreased expression in ND-75<sup>KD</sup> flies.

    Results of GO analysis showing significantly enriched biological process (BP), cellular component (CC) and molecular function (MF) in genes with significantly decreased expression... by Lucy Granat (5570813)

    Published 2023
    Save to List
    Saved in:
  18. 18
    Propofol anesthesia or with surgery decreased the expression of BDNF and p-TrkB, but SAHA reversed the reduction.

    Propofol anesthesia or with surgery decreased the expression of BDNF and p-TrkB, but SAHA reversed the reduction. by Yunlin Feng (3043659)

    Published 2024
    Save to List
    Saved in:
  19. 19
    SQFZ reverses constitutive and PI3K pathway-induced cisplatin resistance.

    SQFZ reverses constitutive and PI3K pathway-induced cisplatin resistance. by Bin Yan (32980)

    Published 2023
    Save to List
    Saved in:
  20. 20
    Significant relationships between QOL measures on infusion day and day 7.

    Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: